NCT03108066 2024-09-24MK-3795-003Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)Phase 2 Completed4 enrolled 11 charts
NCT00088374 2012-07-2717AAG to Treat Kidney Tumors in Von Hippel-Lindau DiseaseNational Institutes of Health Clinical Center (CC)Phase 2 Completed9 enrolled 8 charts